We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Danakali Limited | LSE:DNK | London | Ordinary Share | AU000000DNK9 | ORDS NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.00 | 19.00 | 21.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMDNK
RNS Number : 1878P
Danakali Limited
09 October 2019
Announcement Wednesday, 9 October 2019 ============= ==========================
Issue of shares
Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) is pleased to announce that it has raised A$135,750 through the issue of 250,000 new fully paid shares upon the exercise of unlisted options. A further 15,000 new fully paid shares were issued to an employee on the vesting of performance rights.
A completed Appendix 3B has been lodged together with this announcement.
Secondary Trading Exemption - s708A Notice
Danakali gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act) of the following:
-- The shares were issued without disclosure under Part 6D 2 of the Act; -- This notice is being given under section 708A(5)(e) of the Act; -- As at the date of this notice, the Company has complied with: _ The provisions of Chapter 2M of the Act as they apply to the Company; and _ Section 674 of the Act; and -- As at the date of this notice, there is no information:
_ That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and
_ That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:
o The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or
o The rights and liabilities attaching to the shares.
Total voting rights
The Company advises that it has, conditional on admission, allotted and issued 265,000 new fully paid ordinary shares of no par value in the Company (Ordinary Shares).
Application has been made to the UK Listing Authority for the admission of those 265,000 new Ordinary Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities and it is expected that dealings will commence on 15 October 2019. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.
Following admission, the Company will have in issue a total of 265,587,398 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury.
Therefore, the total number of voting rights in the Company is 265,587,398 which may be used by shareholders or other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Notification of PDMR transaction
The Company advises that the 15,000 new fully paid shares issued on vesting of performance rights were issued to a person discharging managerial responsibilities (PDMR).
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Hot Features
Premium
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Stuart Tarrant
------------------------------------- ---------------------------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------------------------
a) Position/status PDMR (Chief Financial Officer)
------------------------------------- ---------------------------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- ---------------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------------------------
a) Name Danakali Limited
------------------------------------- ---------------------------------------------------------------
b) LEI 5493004SQ5E5Q6VRT472
------------------------------------- ---------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------------------------
a) Description of the Fully paid ordinary shares
financial instrument,
type of instrument
Identification code AU000000DNK9
b) Nature of the Award of shares on the vesting of performance
transaction rights
------------------------------------- ---------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 15,000
-----------------------
------------------------------------- ---------------------------------------------------------------
d) Aggregated information
* Aggregated volume N/A
* Price
* Total
------------------------------------- ---------------------------------------------------------------
e) Date of the transaction 8 October 2019
------------------------------------- ---------------------------------------------------------------
f) Place of the Outside a trading venue
transaction
------------------------------------- ---------------------------------------------------------------
For more information, please contact:
Danakali
Niels Wage William Sandover
Chief Executive Officer Head of Corporate Development &
+61 8 6189 8635 External Affairs
+61 499 776 998
Corporate Broker - Numis Securities UK IR/PR - Instinctif Partners
John Prior / Matthew Hasson / James David Simonson / Sarah Hourahane
Black / / Dinara Shikhametova
Paul Gillam danakali@instinctif.com
+44 (0)20 7260 1000 +44 (0)207 457 2020
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity DANAKALI LTD ABN 56 097 904 302
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities (a) Ordinary shares
issued or to be issued
2 Number of +securities (a) 250,000
issued or to be issued
(if known) or maximum
number which may be
issued
(b) 15,000
3 Principal terms of the (a) Fully paid ordinary shares
+securities (e.g. if (b) Fully paid ordinary shares
options, exercise price
and expiry date; if
partly paid +securities,
the amount outstanding
and due dates for payment;
if +convertible securities,
the conversion price
and dates for conversion)
4 Do the +securities (a) Yes - fully paid ordinary
rank equally in all shares
respects from the (b) Yes - fully paid ordinary
+issue date with shares
an existing +class
of quoted +securities?
If the additional
+securities do not
rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
5 Issue price or consideration (a) $0.543
(b) Nil
6 Purpose of the issue (a) Exercise of unlisted
(If issued as consideration options (Exercise price:
for the acquisition $0.543; expiry 7 October
of assets, clearly 2019)
identify those assets) (b) Vesting of performance
rights (15,000 Class 6)
6a Is the entity an Yes
+eligible entity
that has obtained
security holder approval
under rule 7.1A?
If Yes, complete
sections 6b - 6h
in relation to the
+securities the subject
of this Appendix
3B, and comply with
section 6i
6b The date the security 27 May 2019
holder resolution
under rule 7.1A was
passed
6c Number of +securities Nil
issued without security
holder approval under
rule 7.1
6d Number of +securities Nil
issued with security
holder approval under
rule 7.1A
6e Number of +securities N/A
issued with security
holder approval under
rule 7.3, or another
specific security
holder approval (specify
date of meeting)
6f Number of +securities (a) 250,000
issued under an exception
in rule 7.2
(b) 15,000
6g If +securities issued N/A
under rule 7.1A,
was issue price at
least 75% of 15 day
VWAP as calculated
under rule 7.1A.3?
Include the +issue
date and both values.
Include the source
of the VWAP calculation.
6h If +securities were N/A
issued under rule
7.1A for non-cash
consideration, state
date on which valuation
of consideration
was released to ASX
Market Announcements
6i Calculate the entity's Capacity under L.R.7.1 is
remaining issue capacity 35,028,502
under rule 7.1 and Capacity under LR7.1A is
rule 7.1A - complete 26,594,345
Annexure 1 and release
to ASX Market Announcements
7 +Issue dates 8 October 2019
Note: The issue date
may be prescribed
by ASX (refer to
the definition of
issue date in rule
19.12). For example,
the issue date for
a pro rata entitlement
issue must comply
with the applicable
timetable in Appendix
7A.
Cross reference:
item 33 of Appendix
3B.
Number +Class
Number and +class
of all +securities
quoted on ASX (including
the +securities in
8 section 2 if applicable) 265,587,398 Ordinary Shares
---------------------------------
Number +Class
9 Number and +class
of all +securities 500,000 Unlisted Options
not quoted on ASX exercisable at
(including the +securities $0.912
in section 2 if applicable) each, expiring 11
1,440,000 May 2020
(Remuneration
Options)
1,268,215 Unlisted Options
exercisable at $0.94
each, expiring 19
May 2020
301,040 (Remuneration
Options)
Unlisted Options
583,000 exercisable at
$1.031
each, expiring 24
January 2022
561,800 (Remuneration
Options)
Unlisted Options
1,450,000 exercisable at
$1.031
each, expiring 24
January 2022
280,000 (Remuneration
Options)
800,000
Unlisted Options
100,000 exercisable at
$1.108
25,000 each, expiring 13
March 2022
15,000 (Remuneration
Options)
65,000
Unlisted Options
1,000,000 exercisable at
$1.119
each, expiring 28
March 2022
(Remuneration
Options)
Unlisted Options
exercisable at
$1.114
each, expiring 30
May 2022
(Remuneration
Options)
Performance Rights
- Class 1
Performance Rights
- Class 4
Performance Rights
- Class 5
Performance Rights
- Class 6
Performance Rights
- Class 7
Performance Rights
- Class 8
Performance Rights
- Class 9
-----------------------------------
10 Dividend policy (in N/A
the case of a trust,
distribution policy)
on the increased
capital (interests)
Part 2 -- Pro rata issue
11 Is security holder approval N/A
required?
12 Is the issue renounceable N/A
or non-renounceable?
13 Ratio in which the +securities N/A
will be offered
14 +Class of +securities N/A
to which the offer relates
15 +Record date to determine N/A
entitlements
16 Will holdings on different N/A
registers (or subregisters)
be aggregated for calculating
entitlements?
17 Policy for deciding entitlements N/A
in relation to fractions
18 Names of countries in N/A
which the entity has security
holders who will not be
sent new offer documents
Note: Security holders
must be told how their
entitlements are to be
dealt with.
Cross reference: rule
7.7.
19 Closing date for receipt N/A
of acceptances or renunciations
20 Names of any underwriters N/A
21 Amount of any underwriting N/A
fee or commission
22 Names of any brokers to N/A
the issue
23 Fee or commission payable N/A
to the broker to the issue
24 Amount of any handling N/A
fee payable to brokers
who lodge acceptances
or renunciations on behalf
of security holders
25 If the issue is contingent N/A
on security holders' approval,
the date of the meeting
26 Date entitlement and acceptance N/A
form and offer documents
will be sent to persons
entitled
27 If the entity has issued N/A
options, and the terms
entitle option holders
to participate on exercise,
the date on which notices
will be sent to option
holders
28 Date rights trading will N/A
begin (if applicable)
-----------------
29 Date rights trading will N/A
end (if applicable)
30 How do security holders N/A
sell their entitlements
in full through a broker?
31 How do security holders N/A
sell part of their entitlements
through a broker and
accept for the balance?
32 How do security holders N/A
dispose of their entitlements
(except by sale through
a broker)?
33 +Issue date N/A
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) x +Securities described in Part 1
(b) All other +securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing
the information or documents
35 If the +securities are +equity securities, the
names of the 20 largest holders of the additional
+securities, and the number and percentage of
additional +securities held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting
out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of +securities N/A
for which +quotation
is sought
39 +Class of +securities N/A
for which quotation
is sought
40 Do the +securities N/A
rank equally in all
respects from the +issue
date with an existing
+class of quoted +securities?
If the additional +securities
do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
41 Reason for request N/A
for quotation now
Example: In the case
of restricted securities,
end of restriction
period
(if issued upon conversion
of another +security,
clearly identify that
other +security)
Number +Class
42 Number and +class of N/A N/A
all +securities quoted
on ASX (including the
+securities in clause
38)
---------
Quotation agreement
1 +Quotation of our additional +securities are in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
9 October 2019
Sign here: ............................................................ Date: .........................
(Director/Company secretary)
Catherine Grant-Edwards
Print name: .........................................................
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for (+) eligible entities
Introduced 01/08/12
Part 1
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid
ordinary securities on issue
12 months before date of
issue or agreement to issue 264,197,463
--------------------------------------------------------------------------
Add the following: 216,364 (fully paid ordinary shares
* Number of fully paid ordinary securities issued in issued 7 November 2018 on cashless exercise
that 12 month period under an exception in rule 7.2 of options)
356,049 fully paid ordinary shares issued
24 July 2018 (ratified by shareholders
* Number of fully paid ordinary securities issued in 27 May 2019)
that 12 month period with shareholder approval 8,571 fully paid ordinary shares issued
20 December 2018 (ratified by shareholders
27 May 2019)
* Number of partly paid ordinary securities that became 900,000 (fully paid ordinary shares
fully paid in that 12 month period issued 9 August 2019 on exercise of
options)
250,000 (fully paid ordinary shares
Note: issued 8 October 2019 on exercise of
* Include only ordinary securities here - other classes options)
of equity securities cannot be added 15,000 (fully paid ordinary shares issued
8 October 2019 on vesting of performance
rights)
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
--------------------------------------------------------------------------
Subtract the number of fully N/A
paid ordinary securities
cancelled during that 12
month period
--------------------------------------------------------------------------
"A" 265,943,447
--------------------------------------------------------------------------
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be
changed]
------------------------------------------------------------------
Multiply "A" by 0.15 39,891,517
------------------------------------------------------------------
Step 3: Calculate "C", the amount of placement capacity under
rule 7.1 that has already been used
Insert number of equity securities 1,268,215 unlisted options
issued or agreed to be issued (27 February 2019) (being 1,724,015
in that 12 month period not unlisted options initially
counting those issued: issued less 455,800 unlisted
* Under an exception in rule 7.2 options cancelled 7 June 2019)
583,000 unlisted options (26
March 2019)
* Under rule 7.1A 561,800 unlisted options (18
April 2019)
1,000,000 performance rights
* With security holder approval under rule 7.1 or rule (14 June 2019) (Class 9)
7.4 1,450,000 unlisted options
(14 June 2019)
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable ) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------------------
"C" 4,863,015
------------------------------------------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" x 0.15
Note: number must be same as
shown in Step 2 39,591,517
------------------------------------------------------------------
Subtract "C"
Note: number must be same as
shown in Step 3 4,863,015
------------------------------------------------------------------
Total ["A" x 0.15] - "C" 35,028,502
------------------------------------------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same as shown
in Step 1 of Part 1 265,943,447
-------------------------------------
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be changed
-------------------------------------
Multiply "A" by 0.10 26,594,345
-------------------------------------
Step 3: Calculate "E", the amount of placement capacity under
rule 7.1A that has already been used
Insert number of equity securities Nil
issued or agreed to be issued in
that 12 month period under rule
7.1A
Notes:
-- This applies to equity securities
- not just ordinary securities
-- Include here - if applicable
- the securities the subject of
the Appendix 3B to which this form
is annexed
-- Do not include equity securities
issued under rule 7.1 (they must
be dealt with in Part 1), or for
which specific security holder
approval has been obtained
-- It may be useful to set out
issues of securities on different
dates as separate line items
-------------------------------------
"E" Nil
-------------------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement
capacity under rule 7.1A
"A" x 0.10
Note: number must be same as shown
in Step 2 26,594,345
-------------------------------------
Subtract "E" Nil
Note: number must be same as shown
in Step 3
-------------------------------------
Total ["A" x 0.10] - "E" 26,594,345
-------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHUGGQPUUPBGCR
(END) Dow Jones Newswires
October 09, 2019 02:00 ET (06:00 GMT)
1 Year Danakali Chart |
1 Month Danakali Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
